D.E. Shaw & Co
LMAT icon

D.E. Shaw & Co’s LeMaitre Vascular LMAT Stock Holding History

D.E. Shaw & Co’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
36,464
-47,165
-56% -$4.84M ﹤0.01% 2703
2026
Q1 		$9.13M Buy
83,629
+40,826
+95% +$3.89M 0.01% 1719
2025
Q4 		$3.47M Sell
42,803
-3,902
-8% -$336K ﹤0.01% 2607
2025
Q3 		$4.09M Buy
46,705
+34,408
+280% +$3.07M ﹤0.01% 2387
2025
Q2 		$1.02M Sell
12,297
-42,716
-78% -$3.57M ﹤0.01% 3224
2025
Q1 		$4.62M Buy
55,013
+36,442
+196% +$3.39M ﹤0.01% 1956
2024
Q4 		$1.71M Sell
18,571
-31,233
-63% -$3M ﹤0.01% 2841
2024
Q3 		$4.63M Buy
49,804
+20,329
+69% +$1.76M ﹤0.01% 2007
2024
Q2 		$2.43M Buy
+29,475
New +$2.17M ﹤0.01% 2485
2024
Q1 		– Sell
-9,129
Closed -$518K – 4565
2023
Q4 		$518K Sell
9,129
-27,796
-75% -$1.46M ﹤0.01% 3497
2023
Q3 		$2.01M Sell
36,925
-24,667
-40% -$1.46M ﹤0.01% 2559
2023
Q2 		$4.14M Buy
+61,592
New +$3.76M ﹤0.01% 2012
2021
Q3 		– Sell
-4,619
Closed -$282K – 5095
2021
Q2 		$282K Sell
4,619
-14,012
-75% -$744K ﹤0.01% 4310
2021
Q1 		$909K Buy
18,631
+5,555
+42% +$260K ﹤0.01% 3190
2020
Q4 		$530K Buy
+13,076
New +$467K ﹤0.01% 3361
2019
Q4 		– Sell
-10,745
Closed -$367K – 4076
2019
Q3 		$367K Buy
10,745
+2,838
+36% +$90.7K ﹤0.01% 3354
2019
Q2 		$221K Sell
7,907
-300
-4% -$8.34K ﹤0.01% 3430
2019
Q1 		$254K Buy
+8,207
New +$219K ﹤0.01% 3288
2016
Q4 		– Sell
-30,808
Closed -$611K – 3528
2016
Q3 		$611K Buy
+30,808
New +$538K ﹤0.01% 2679

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co's LMAT Position: Q2 2026 in Review

D.E. Shaw & Co reduced its LeMaitre Vascular (LMAT) stake by 56% in Q2 2026, selling an estimated $4.84M and leaving 36,464 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

D.E. Shaw & Co first reported a position in LMAT in Q3 2016 and has held it in 19 quarters since. The position peaked at $9.13M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • D.E. Shaw & Co held 36,464 shares of LeMaitre Vascular worth $3.5M as of Q2 2026.
  • D.E. Shaw & Co sold 47,165 LeMaitre Vascular shares in Q2 2026, an estimated $4.84M.
  • LeMaitre Vascular made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2703 holding.
  • D.E. Shaw & Co first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 19 quarters since.
  • D.E. Shaw & Co's LeMaitre Vascular position peaked at $9.13M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.